Literature DB >> 21706132

Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.

Hai Tao Niu1, Chuan Min Yang, Gang Jiang, Ting Xu, Yan Wei Cao, Jun Zhao, Xin Sheng Wang.   

Abstract

PURPOSE: To globally characterize the stroma expression profile of superficial bladder transitional cell carcinoma and to discuss the cancer biology as well as biomarker discovery from stromal cells.
METHODS: Laser capture microdissection was used to harvest purified bladder cancer stromal cells and normal stromal cells from 4 paired samples. Next, two-dimensional liquid chromatography-tandem mass spectrometry was used to identify the proteome expression profile. The differential proteins were further analyzed using bioinformatics tools and compared with the published literature.
RESULTS: A total of 606/601 proteins commonly appeared in 4 paired samples. Six hundred and thirty-seven proteins were differentially expressed between cancer and normal stroma. Among them, 321/316 proteins specific expressed in cancer/normal stromal cells. Differential proteins were compared with the entire list of the international protein index (IPI). 36/49 GO terms exhibited as enriched and 25/14 exhibited as depleted in biological process; 39/40 GO terms exhibited as enriched and 9/4 exhibited as depleted in cellular component, respectively. Significantly altered pathways between cancer/normal stroma mainly include focal adhesion, EHEC, oxidative phosphorylation, glycolysis/gluconeogenesis, TCA cycle. Finally, descriptive statistics show the data that PI ≤ 8 have normal distribution and the proteins with extremes of PI and MW have the same probability to be a biomarker.
CONCLUSIONS: The present study identified the proteome expression profile of bladder cancer stromal cells and normal stromal cells. Furthermore, our results confirm proteins origin from stroma play important role in cancer biology and highlight a novel view of cancer and stress the importance of including factors related to the cancer stroma into biomarker discovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21706132     DOI: 10.1007/s00432-011-0995-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

Review 1.  Complementary methods to assist subcellular fractionation in organellar proteomics.

Authors:  Daniel J Gauthier; Claude Lazure
Journal:  Expert Rev Proteomics       Date:  2008-08       Impact factor: 3.940

Review 2.  Dysregulation of protein synthesis and disease.

Authors:  John P C Le Quesne; Keith A Spriggs; Martin Bushell; Anne E Willis
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

3.  Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.

Authors:  Chien-Feng Li; Kun-Hung Shen; Li-Chien Huang; Hsuan-Ying Huang; Yu-Hui Wang; Ting-Feng Wu
Journal:  Pathology       Date:  2010-01       Impact factor: 5.306

4.  Heat-killed bacteria induce genome instability in mouse small intestine, liver and spleen tissues.

Authors:  Igor Koturbash; James E Thomas; Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2009-06-20       Impact factor: 4.534

Review 5.  The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox.

Authors:  Mei Chung Moh; Shali Shen
Journal:  Cell Adh Migr       Date:  2009-10-12       Impact factor: 3.405

Review 6.  Mitochondrial metabolism and cancer.

Authors:  Frank Weinberg; Navdeep S Chandel
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 7.  The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression.

Authors:  R Wäsch; J A Robbins; F R Cross
Journal:  Oncogene       Date:  2009-10-12       Impact factor: 9.867

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2.

Authors:  Rob Stierum; Marco Gaspari; Yvonne Dommels; Taoufik Ouatas; Helma Pluk; Sonja Jespersen; Jack Vogels; Kitty Verhoeckx; John Groten; Ben van Ommen
Journal:  Biochim Biophys Acta       Date:  2003-08-21

10.  Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+.

Authors:  Stéphanie De Simoni; Julie Goemaere; Bernard Knoops
Journal:  Neurosci Lett       Date:  2008-01-17       Impact factor: 3.046

View more
  6 in total

Review 1.  Developing proteomic biomarkers for bladder cancer: towards clinical application.

Authors:  Maria Frantzi; Agnieszka Latosinska; Leif Flühe; Marie C Hupe; Elena Critselis; Mario W Kramer; Axel S Merseburger; Harald Mischak; Antonia Vlahou
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

2.  Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.

Authors:  Chien-Lun Chen; Ting Chung; Chih-Ching Wu; Kwai-Fong Ng; Jau-Song Yu; Cheng-Han Tsai; Yu-Sun Chang; Ying Liang; Ke-Hung Tsui; Yi-Ting Chen
Journal:  Mol Cell Proteomics       Date:  2015-06-16       Impact factor: 5.911

3.  Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.

Authors:  Lei Wang; Xudong Liu; Miao Yue; Zhe Liu; Yu Zhang; Ying Ma; Jia Luo; Wuling Li; Jiangshan Bai; Hongmei Yao; Yuxuan Chen; Xiaofeng Li; Dayun Feng; Xinqiang Song
Journal:  Cancer Rep (Hoboken)       Date:  2021-09-20

Review 4.  Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.

Authors:  Lucien McBeth; Maria Grabnar; Steven Selman; Terry D Hinds
Journal:  Int J Endocrinol       Date:  2015-08-10       Impact factor: 3.257

5.  MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Authors:  Eldo T Verghese; Ruth Drury; Caroline A Green; Deborah L Holliday; Xiaomei Lu; Claire Nash; Valerie Speirs; James L Thorne; Helene H Thygesen; Alexandre Zougman; Mark A Hull; Andrew M Hanby; Thomas A Hughes
Journal:  J Pathol       Date:  2013-11       Impact factor: 7.996

Review 6.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.